CAVAL US-guided Therapy
OtherPatients randomly assigned to this group will receive a daily CAVAL US exam guided decongestive therapy accessible to treating medical team, in addition to the standard care.
NCT Number: NCT04549701
Between 25% and 30% of patients hospitalized for acute heart failure (AHF) are readmitted within 90 days after discharge. Mostly due to persistent congestion on discharge. However, as the optimal evaluation of decongestion is not clearly defined, it is necessary to implement new tools to identify subclinical congestion to guide treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Instituto Cardiovascular de Buenos Aires, Buenos Aires, Buenos Aires City, Argentina
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
and - Jugular venous distension, hepatojugular reflux, lower extremity edema or signs of pulmonary congestion.
and
and
Exclusion criteria
Patients randomly assigned to this group will receive a daily CAVAL US exam guided decongestive therapy accessible to treating medical team, in addition to the standard care.
Standard of care will be provided.
Time frame: Discharge
Time frame: 90 days
Readmission for heart failure: unscheduled urgent hospital visit and stay longer than 24 hours, requiring medical interventions.
Mortality: death of the patient. Unplanned visit for worsening heart failure: unscheduled visit to the emergency department that led to an increase in oral / intravenous therapy, stay less than 24 hours.
Instituto Cardiovascular de Buenos Aires
Other
Inferior Vena CAVA and Lung UltraSound-guided Therapy in Acute Heart Failure: a Randomized Controlled Pilot Trial (CAVAL US-AHF Study)
Acronym: CAVAL US-AHF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04363697
Acute Heart Failure, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT03892148
Acute Heart Failure, Cardiovascular Diseases
Annecy, France
View Trial DetailsNCT04829591
Acute Heart Failure, Cardiovascular Diseases
Amman, Jordan
View Trial DetailsNCT05962255
Acute Heart Failure, Cardiovascular Diseases
Wroclaw, Lower Silesian Voivodeship, Poland
View Trial Details